Literature DB >> 23899986

Using a psychosocial registry as a data source for nurses.

Carol G Kelley1, Amy R Lipson, Barbara Daly, Sara L Douglas.   

Abstract

Nurses at the bedside strive to base their practice on the best available information derived from evidence. However, issues related to patient care often arise for which evidence is either difficult to attain or not available. This can be particularly true for nurses who care for patients with diverse diagnoses because most studies focus on patients with a single cancer diagnosis. For example, evidence about quality of life (QOL) as perceived by the patient is a concern for clinicians but is of particular importance to nurses at the bedside. A great deal of study has been performed on the QOL of patients with cancer; however, most of these reports focus on narrow or limited samples, typically one specific cancer type. Having access to a registry that enrolls patients with diverse types of cancer and collects QOL data could be very useful to practicing bedside nurses.

Entities:  

Mesh:

Year:  2013        PMID: 23899986      PMCID: PMC4370172          DOI: 10.1188/13.CJON.444-446

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  15 in total

1.  Predictors of quality of life in newly diagnosed melanoma and breast cancer patients.

Authors:  U-S Lehto; M Ojanen; P Kellokumpu-Lehtinen
Journal:  Ann Oncol       Date:  2005-04-07       Impact factor: 32.976

2.  Quality of life outcomes are equivalent after lobectomy in the elderly.

Authors:  William R Burfeind; Betty C Tong; Erin O'Branski; James E Herndon; Eric M Toloza; Thomas A D'Amico; Linda H Harpole; David H Harpole
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09       Impact factor: 5.209

3.  Use of a self-report-generated Charlson Comorbidity Index for predicting mortality.

Authors:  Saima Chaudhry; Lei Jin; David Meltzer
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

4.  Psychosocial registry for persons with cancer: a method of facilitating quality of life and symptom research.

Authors:  Barbara J Daly; Sara L Douglas; Helen Foley; Amy Lipson; Chiou-Fang Emily Liou; Karen Bowman; Donna Kwilosz; Siran Koroukian; Elizabeth O'Toole; Kathleen Smyth; Aloen Townsend; Vivian VonGruenigen; Julia Rose
Journal:  Psychooncology       Date:  2007-04       Impact factor: 3.894

5.  Impact of newly diagnosed breast cancer on quality of life among Chinese women.

Authors:  Wei Lu; Yong Cui; Ying Zheng; Kai Gu; Hui Cai; Qiong Li; Wei Zheng; Xiao Ou Shu
Journal:  Breast Cancer Res Treat       Date:  2006-07-19       Impact factor: 4.872

6.  Prospective study of quality of life in adults with newly diagnosed high-grade gliomas.

Authors:  Paul D Brown; Karla V Ballman; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Bradley F Boeve; Lalit Gupta; David F Tang-Wai; Robert M Arusell; Matthew M Clark; Jan C Buckner
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

7.  General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G).

Authors:  Penny S Brucker; Kathleen Yost; John Cashy; Kimberly Webster; David Cella
Journal:  Eval Health Prof       Date:  2005-06       Impact factor: 2.651

Review 8.  Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations.

Authors:  T Luckett; M T King; P N Butow; M Oguchi; N Rankin; M A Price; N A Hackl; G Heading
Journal:  Ann Oncol       Date:  2011-02-21       Impact factor: 32.976

9.  Health status and quality of life among non-Hodgkin lymphoma survivors.

Authors:  Sophia K Smith; Sheryl Zimmerman; Christianna S Williams; Bradley J Zebrack
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

10.  Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma.

Authors:  Kathrin Strasser-Weippl; Heinz Ludwig
Journal:  Eur J Haematol       Date:  2008-07-11       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.